Committees
Several committees oversee EORTC’s strategy and independence as well as the relevance and scientific value of all research efforts, ensuring scientific work is of the highest possible quality. Each EORTC committee chair is elected to serve a three-year term which may be renewed upon recommendation by the EORTC Board.
Protocol Review Committee
The Protocol Review Committee (PRC), which is appointed by the EORTC Board, comprises experts in all disciplines of oncology, 50% of whom are not EORTC members. In addition, the PRC makes systematic use of external reviewers – a minimum of three international experts are consulted for each outline, providing an independent review.
The PRC reviews and approves all research projects proposed by EORTC groups. The Translational Research Advisory Committee (TRAC) provides additional scientific expertise when needed. The New Drug Advisory Committee (NDAC) supports the evaluation of new molecules incoming in the EORTC.
-
R. Schilsky - Alexandria, US
ChairAmerican Society of Clinical Oncology
-
F. Shepherd - Toronto, CA
Vice-ChairUniversity Health Network - Oci / Princess Margaret Hospital
-
F. Alongi - Verona, IT
MemberSacro Cuore Hospital
-
F. Baron - Liège, BE
MemberC.H.U. Sart-Tilman
-
A. Beer - Ulm, DE
MemberUniversitaetsklinikum Ulm
-
L. Blomqvist - Stockholm, SE
MemberKarolinska University Hospital, location Solna
-
S. Bodis - Aarau, CH
MemberKantonsspital Aarau
-
F. Brunotte - Dijon, FR
MemberCentre Georges-Francois-Leclerc
-
A. Chiti - Milano, IT
MemberIstituto Clinico Humanitas
-
K. Conlon - Dublin, IE
MemberTrinity College - University Of Dublin
-
V. Dieras - Paris, FR
MemberInstitut Curie
-
M. Guckenberger - Zurich, CH
MemberUniversitaetsSpital Zurich
-
P. Goodwin - Toronto, CA
MemberMount Sinai Hospital
-
E. Haglind - Goteborg, SE
MemberSahlgrenska Universitetssjukhuet
-
P. Hoskin - Northwood, GB
MemberEast and North Hertfordshire NHS Trust – Mount Vernon Hospital
-
N. Isambert - Dijon, FR
MemberCentre Georges-Francois-Leclerc
-
A. Jimeno - Denver, US
MemberUniversity Of Colorado Cancer Center
-
S. Mandrekar - Rochester, US
MemberMayo Clinic
-
G. Marcucci - Duarte, US
MemberCity Of Hope National Medical Center
-
S. Michiels - Villejuif, FR
MemberGustave Roussy
-
J. Oliveira - Lisboa, PT
MemberI.P.O. Francisco Gentil - Centro De Lisboa
-
M. Redman - Seattle, US
MemberFred Hutchison Seattle Cancer Care Alliance
-
J. Rodon - Barcelona, ES
MemberHospital General Vall D'Hebron
-
A. Sobrero - Genova, IT
MemberOspedale San Martino / Cliniche Universitarie Convenzionale
-
M. Sydes - London, GB
MemberMRC Clinical Trials Office
-
G. Velikova - Leeds, GB
MemberLeeds Teaching Hospitals NHS Trust - St. James's University Hospital
-
M. Eriksson - Lund, SE
MemberSkane University Hospital
-
A. Elias - Denver, US
Phase I-II PRC ExpertUniversity Of Colorado Cancer Center
-
H. Hirte - Hamilton, CA
Phase I-II PRC ExpertHamilton Health Sciences, Juravinski Cancer Centre
-
I. Judson - London, GB
Phase I-II PRC ExpertThe Royal Marsden Hospital
-
P. O'Dwyer - Philadelphia, US
Phase I-II PRC ExpertUniversity Of Pennsylvania - Presbyterian Medical Center
-
W. Parulekar - Kingston, CA
Phase I-II PRC ExpertCCTG - Queen'S University
-
D. Ross Camidge - Denver, US
Phase I-II PRC ExpertUniversity Of Colorado Cancer Center
-
L. Siu - Toronto, CA
Phase I-II PRC ExpertUniversity Health Network - Oci / Princess Margaret Hospital
-
D. Lacombe - Brussels, BE
Ex-Officio MemberEORTC Headquarters
Independent Data Monitoring Committee
The Independent Data Monitoring Committee (IDMC) conducts interim reviews of EORTC studies and intergroup studies where the EORTC is the coordinating group (including studies done in partnership with the pharmaceutical industry).
The IDMC will make recommendations on whether or not to pursue or adapt a clinical trial based on scientific, ethical, statistical or safety considerations.
-
M. Mason - Cardiff, GB
ChairVelindre NHS Trust - Velindre Cancer Centre
-
G. Griffiths - Southampton, GB
MemberSouthampton Clinical Trials Unit, University of Southampton
-
E. Calvo - Madrid, ES
MemberSTART Madrid
-
D. Zips - Tübingen, DE
MemberUniversity Hospital Tübingen
The permanent IDMC for EORTC studies functions according to a Charter and a policy.
All communication with the IDMC should be addressed in writing to IDMCsec@eortc.org.
New Drug Advisory Committee
The New Drug Advisory Committee (NDAC) acts as a reference body for all EORTC groups, and makes recommendations to them on all aspects of drug development, including selecting the most promising compounds.
The committee focuses on molecules that have not been registered or are not already used in oncology. Working closely with the Early Project Optimisation Department within EORTC, NDAC helps design of clinical studies evaluating these treatments, advises the Board on project reviews and makes connections with industry partners.
-
J. Bizzari - Haverford, US
Chair -
A. Astier - Paris, FR
MemberAssistance Publique - Hopitaux de Paris - CHU Henri Mondor
-
A. Awada - Brussels, BE
MemberHopitaux Universitaires Bordet-Erasme - Institut Jules Bordet
-
U. Banerji - Sutton, GB
MemberRoyal Marsden Hospital
-
J. Dancey - Kingston, CA
MemberCCTG - Queen'S University
-
K. Dhingra - Sparta, US
Member -
J. Martens - Rotterdam, NL
MemberErasmus MC
-
G. Peters - Amsterdam, NL
MemberVU University Medical Center
-
J. Tabernero - Barcelona, ES
MemberHospital General Vall D'Hebron
-
N. Harbeck - Munich, DE
Ex Officio memberKlinikum der Universitaet Muenchen - Campus Grosshadern
-
S. Tejpar - Leuven, BE
Ex Officio memberU.Z. Leuven - Campus Gasthuisberg
Scientific Audit Committee
The EORTC Scientific Audit Committee (SAC) gives independent advice to the EORTC Board on the activities, scientific output, overall priorities and strategies of the EORTC. The SAC evaluates the effectiveness of research programmes and makes suggestions to strengthen the EORTC’s overall functioning. The committee’s members represent a cross-section of international opinion leaders and experts, half of whom have no other EORTC involvement.
-
E. Eisenhauer - Kingston, CA
ChairQueen’s University
-
J. Pierga - Paris, FR
SecretaryInstitut Curie
-
J. De Bono - Sutton, GB
MemberRoyal Marsden Hospital
-
L. Ellis - Houston, US
MemberMD Anderson Cancer Center
-
C. Grau - Aarhus , DK
MemberAarhus University Hospital
-
D. Lacombe - Brussels, BE
MemberEORTC Headquarters
-
P. Ljungman - Stockholm, SE
MemberKarolinska University Hospital , location Huddinge
-
K. Margolin - Seattle, US
MemberFred Hutchison Seattle Cancer Care Alliance
-
J. Radford - Manchester, GB
MemberThe Christie NHS Foundation Trust
-
E. Rutgers - Amsterdam, NL
MemberThe Netherlands Cancer Institute
Antoni van Leeuwenhoekziekenhuis -
E. Voest - Amsterdam, NL
MemberNetherlands Cancer Institute (NKI)
-
J. Jassem - Gdansk, PL
MemberMedical University Of Gdansk
Quality Assurance Committee
The primary objective of the Quality Assurance Committee (QAC) is to ensure compliance with Good Clinical Practice and new directives/guidelines from Regulatory Authorities, assessing potential serious non-compliance issues and recommending corrective actions. In addition, the committee recommends ways to develop and continuously improve transversal quality assurance strategies and initiatives in transversal fields such as radiotherapy, surgery and pathobiology.
New Chair to be appointed.
-
C. de Balincourt - Brussels, BE
SecretaryEORTC Headquarters
-
C. Coens - Brussels, BE
MemberEORTC Headquarters
-
M. den Dulk - Maastricht, NL
MemberAcademisch Ziekenhuis Maastricht
-
P. Hau - Regensburg, DE
MemberUniversitaetskliniken Regensburg
-
B. Kasper - Mannheim, DE
MemberMannheim University Medical Center
-
D. Lacombe - Brussels, BE
MemberEORTC Headquarters
-
L. Licitra - Milano, IT
MemberFondazione IRCCS, Istituto Nazionale dei Tumori
-
M. Spahn - Bern, CH
MemberInselspital
-
J. Machiels - Brussels, BE
MemberCliniques Universitaires Saint-Luc
-
R. Salgado - Brussels, BE
MemberBreast Cancer Translational Research Laboratory
-
D. Weber - Villigen, CH
MemberPaul Scherrer Institute - Center for Proton Therapy (CPT)
Translational Research Advisory Committee
The Translational Research Advisory Committee (TRAC) provides expert advice on translational research projects conducted within the EORTC and stimulates new translational research trials using existing clinically-annotated biosamples. TRAC comprises permanent and ex officio members representing all the main disciplines of translational research in oncology.
-
S. Tejpar - Leuven, BE
ChairU.Z. Leuven - Campus Gasthuisberg
-
M. Daidone - Milano, IT
Vice-ChairFondazione IRCCS Istituto Nazionale dei Tumori
-
H. Allgayer - Mannheim, DE
MemberUniversitaetsMedizin Mannheim
-
N. Bruenner - Copenhagen, DK
MemberUniversity of Copenhagen-Lifepharm Center
-
M. Callari - Cambridge , GB
MemberCruk Cambridge Institute
-
F. Cardoso - Lisbon, PT
MemberChampalimaud Cancer Center
-
N. deSouza - Sutton, GB
MemberRoyal Marsden Hospital Sutton
-
S. Eppenberger - Basel, CH
MemberUniversity Hospital Basel
-
C. Fink - Celle, DE
MemberAllgemeines Krankenhaus Celle
-
T. Gevaert - Leuven, BE
MemberCatholic University Leuven
-
R. Giavazzi - Bergamo, IT
MemberLaboratori Of Biology Mario Negri Institute
-
M. Hegi - Lausanne, CH
MemberLaboratory of Brain Tumor Biology and Genetics – CHUV
-
R. Iggo - Bordeaux, FR
MemberInstitut Bergonie - Laboratoire De Biochimie
-
T. Turnsek - Ljubljana, SI
MemberNational Institute of Biology
-
P. Lambin - Maastricht , NL
MemberMaastro Clinic - Maastricht Radiation Oncology
-
J. Martens - Rotterdam, NL
MemberErasmus MC
-
S. Michiels - Villejuif, FR
MemberGustave Roussy
-
F. Mottaghy - Aachen, DE
MemberUniversitätsklinikum Aachen AÖR - Medizinische Fakultät der RWTH
-
K. Pantel - Hamburg, DE
MemberUniversitaets-Krankenhaus Eppendorf
-
P. Perego - Milano, IT
MemberIstituto Nazionale dei Tumori di Milano
-
G. Peters - Amsterdam, NL
MemberVU University Medical Center
-
A. Rhodes - Bristol, GB
MemberThe University of the West of England - Frenchay Campus
-
E. Rouleau - Paris, FR
MemberInstitut Gustave Roussy
-
R. Salgado - Brussels, BE
MemberBreast Cancer Translational Research Laboratory
-
I. Skvortsova - Innsbruck, AT
MemberInnsbruck Universitaetsklinik
-
P. Span - Nijmegen, NL
MemberRadboud University Medical Center Nijmegen
-
F. Sweep - Nijmegen, NL
MemberRadboud University Medical Center Nijmegen
-
G. Van den Eynden - Brussels, BE
MemberInstitut Jules Bordet, GasthuisZustersAntwerpen
-
L. Van Kempen - Montreal, CA
MemberJewish General Hospital
-
N. Zaffaroni - Milano, IT
MemberFondazione IRCCS Istituto Nazionale dei Tumori
-
J. Bizzari - Haverford, US
Ex Officio member
Membership Committee
The Membership Committee assesses the qualifications and expertise available at research institutions and coordinates their affiliation with the EORTC network.
-
A. Marinus - Brussels, BE
SecretaryEORTC Headquarters
-
T. Conroy - Vandoeuvre-Les-Nancy, FR
MemberInstitut de Cancérologie de Lorraine
-
M. Groenvold - Copenhagen, DK
MemberBispebjerg Hospital
-
E. Lartigau - Lille, FR
MemberCentre Oscar Lambret
-
J. Vermorken - Edegem, BE
MemberUniversitair Ziekenhuis Antwerpen
Institutional Review Board
EORTC’s Institutional Review Board (IRB) is responsible for safeguarding the rights and welfare of those participating in clinical trials it supports. This includes protecting the privacy and confidentiality of patient data and validating informed consent and patient information document templates. All institutions and investigators submitting data to the body’s headquarters agree to abide by the decisions of the IRB regarding data collection, transfer, storage, release, retention, and disposition, as these pertain to individual patient privacy and confidentiality. The IRB also reviews potential conflicts of interest reported to headquarters.
-
A. Negrouk - Brussels, BE
ChairEORTC Headquarters
-
F. Crawley - Antwerp, BE
MemberGood Clinical Practice Alliance
-
C. de Balincourt - Brussels, BE
MemberEORTC Headquarters
-
C. Fortpied - Brussels, BE
MemberEORTC Headquarters
-
J. Geissler - Munich, DE
MemberEuropean Patients' Academy on Therapeutic Innovation
-
J. Otten - Brussels, BE
MemberUniversitair Ziekenhuis Brussel
-
P. Ruyskart - Brussels, BE
MemberEORTC Headquarters
The Radiation Oncology Science Council (ROSC)
The Radiation Oncology Science Council (ROSC) was created as a think-tank to stimulate exchanges among the EORTC Disease-Oriented Groups network and to identify new areas of research in radiation therapy.
- It will actively promote radiation therapy both within the EORTC and beyond.
- It will act as radiotherapy reference for the EORTC, including for the disease oriented groups and the EORTC Board, and the radiation therapy quality assurance community.
- It will identify and define radiation oncology research questions and support ongoing EORTC activity in the field of radiation therapy.
- It will represent the EORTC and its network of sites when called upon to encourage the development and implementation of RT initiatives both nationally and internationally.
-
P. Ost - Ghent, BE
ChairUniversitair Ziekenhuis Gent
-
Y. Lievens - Gent, BE
MemberUniversitair Ziekenhuis Gent
-
M. Guckenberger - Zurich, CH
MemberUniversitaetsSpital Zurich
-
S. Lukacova - Aarhus, DK
MemberAarhus University Hospital-Skejby
-
F. Dhermain - Villejuif, FR
MemberGustave Roussy
-
C. Faivre-Finn - Manchester, GB
MemberThe Christie NHS Foundation Trust
-
A. Levy - Villejuif, FR
MemberGustave Roussy
-
P. Dirix - Wilrijk, BE
MemberGasthuisZusters Antwerpen - Sint-Augustinus
-
E. Orlandi - Pavia, IT
Memberentro Nazionale di Adroterapia Oncoloica par il trattamento dei tumori
-
E. Ozsahin - Lausanne, CH
MemberCentre Hospitalier Universitaire Vaudois - Lausanne
-
I. Meattini - Firenze, IT
MemberAzienda Ospedaliero-Universitaria Careggi
-
T. Marinko - Ljubljana, SI
MemberThe Institute Of Oncology
-
J. Stelmes - Zurich, CH
MemberUniversitaetsSpital Zurich
-
R. Haas - Amsterdam, NL
MemberThe Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis
-
K. Haustermans - Leuven, BE
MemberU.Z. Leuven - Campus Gasthuisberg
-
E. Deutsch - Villejuif, FR
MemberGustave Roussy
-
F. Herrera - Lausanne, CH
MemberCentre Hospitalier Universitaire Vaudois
-
P. Meijnders - Antwerp, BE
MemberIridium Cancer Network Antwerp/GZA
-
R. Cowan - Manchester, GB
MemberThe Christie NHS Foundation Trust
-
J. Verhoeff - Utrecht, NL
MemberUMC-Academisch Ziekenhuis Utrecht
-
N. Reynaert - Brussels, BE
MemberInstitut Jules Bordet-Hopital Universitaire ULB
-
C. Hurkmans - Eindhoven, NL
MemberCatharina Ziekenhuis
-
M. Walczak - Kielce, PL
Member -
E. Rivin del Campo - Paris, FR
MemberAssistance Publique - Hopitaux de Paris - Hopital Tenon
-
B. Fournier - Brussels, BE
MemberEORTC Headquarters
-
E. Clementel - Brussels, BE
MemberEORTC Headquarters